
Procter & Gamble ownership: holders and insider trading
$172.46−0.33%Close 17 Nov 2026 · Market value $400.7B
As filed, its directors and officers own 0.2% of the shares (proxy statement, 30 Jun 2026); 4,015 institutional managers reported holding 70.5% at 30 Jun 2026. Over the last twelve months, insiders sold $93.91M of shares on the open market, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Vanguard Capital Management | Holder | 175M | 7.52% | Proxy statement | 30 Jun 2026 |
|---|
| BlackRock, Inc. | Holder | 156M | 6.7% | Proxy statement | 30 Jun 2026 |
|---|
| State Street | Institution | 102M | 4.41%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 66.5M | 2.87%* | Form 13F | 30 Jun 2026 |
|---|
| Charles Schwab | Institution | 47.3M | 2.04%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 47.2M | 2.03%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 31.8M | 1.37%* | Form 13F | 30 Jun 2026 |
|---|
| Fidelity (FMR) | Institution | 29.3M | 1.26%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 28.9M | 1.25%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 28.4M | 1.23%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 26.8M | 1.16%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 26.8M | 1.16%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 26.3M | 1.13%* | Form 13F | 30 Jun 2026 |
|---|
| Capital Group | Institution | 24.2M | 1.04%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 23.7M | 1.02%* | Form 13F | 30 Jun 2026 |
|---|
| Goldman Sachs | Institution | 16.8M | 0.72%* | Form 13F | 30 Jun 2026 |
|---|
| State Farm Mutual Automobile Insurance Co | Institution | 15.8M | 0.68%* | Form 13F | 30 Jun 2026 |
|---|
| BNY | Institution | 15.6M | 0.67%* | Form 13F | 30 Jun 2026 |
|---|
| Royal Bank of Canada | Institution | 15.0M | 0.65%* | Form 13F | 30 Jun 2026 |
|---|
| Legal & General | Institution | 14.6M | 0.63%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Abd El Hak Hesham · CEO-Baby and Feminine Care | 12 Nov 2026 | Open-market sale | −2.3K | $168.47 | $379.1K |
|---|
| Schulten Andre · Chief Financial Officer | 5 Nov 2026 | Option exercise | +30.7K | $78.52 | $2.41M |
|---|
| Schulten Andre · Chief Financial Officer | 5 Nov 2026 | Open-market sale | −30.7K | $169.00 | $5.18M |
|---|
| Santos de Azevedo Juliana Monteiro · CEO - Grooming | 5 Nov 2026 | Open-market sale | −5.4K | $169.00 | $907.5K |
|---|
| Schulten Andre · Chief Financial Officer | 4 Nov 2026 | Option exercise | +33.6K | $91.07 | $3.06M |
|---|
| Schulten Andre · Chief Financial Officer | 4 Nov 2026 | Open-market sale | −33.6K | $165.00 | $5.55M |
|---|
| Janzaruk Matthew W. · SVP - Chief Accounting Officer | 3 Nov 2026 | Option exercise | +9.5K | $98.55 | $934.2K |
|---|
| Janzaruk Matthew W. · SVP - Chief Accounting Officer | 3 Nov 2026 | Open-market sale | −9.5K | $163.00 | $1.55M |
|---|
| Gama Paul · CEO- Health Care | 30 Oct 2026 | Open-market sale | −2.9K | $165.00 | $477.5K |
|---|
| Aguilar Moses Victor Javier · Chf Rsch, Dev & Innov Officer | 30 Oct 2026 | Option exercise | +18.8K | $78.52 | $1.48M |
|---|
| Aguilar Moses Victor Javier · Chf Rsch, Dev & Innov Officer | 30 Oct 2026 | Open-market sale | −18.8K | $164.43 | $3.09M |
|---|
| Raman Sundar G. · CEO-Fabric Home & Habitat Care | 30 Oct 2026 | Option exercise | +38.3K | $98.55 | $3.77M |
|---|
| Raman Sundar G. · CEO-Fabric Home & Habitat Care | 30 Oct 2026 | Open-market sale | −38.3K | $165.00 | $6.31M |
|---|
| Jejurikar Shailesh · Chairman, President and CEO · Director | 23 Oct 2026 | Option exercise | +35.0K | $78.52 | $2.75M |
|---|
| Jejurikar Shailesh · Chairman, President and CEO · Director | 23 Oct 2026 | Open-market sale | −35.0K | $163.09 | $5.71M |
|---|
| Purushothaman Balaji · Chief Human Resources Officer | 23 Oct 2026 | Open-market sale | −4.2K | $160.71 | $671.9K |
|---|
| Gama Paul · CEO- Health Care | 23 Oct 2026 | Open-market sale | −4.3K | $161.27 | $698.5K |
|---|
| Subramaniam Rajesh · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| Portman Robert Jones · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| McEvoy Ashley · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| McCarthy Christine M · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| Kempczinski Christopher J · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| JIMENEZ JOSEPH · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| Chang Amy · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
| Bonini Sheila · Director | 13 Oct 2026 | Grant or award | +1.4K | — | — |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
PG in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.